Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/174434
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLinares Galiana, Isabel-
dc.contributor.authorBerenguer Francés, Miguel Ángel-
dc.contributor.authorCañas Cortés, Rut-
dc.contributor.authorPujol Canadell, Monica-
dc.contributor.authorComas Antón, Silvia-
dc.contributor.authorMartínez, Evelyn-
dc.contributor.authorLaplana, Maria-
dc.contributor.authorPérez Montero, Héctor-
dc.contributor.authorPla Farnós, María Jesús-
dc.contributor.authorNavarro Martin, Arturo-
dc.contributor.authorNuñez, Miriam-
dc.contributor.authorBoth, Brigitte-
dc.contributor.authorGuedea Edo, Ferran-
dc.date.accessioned2021-03-01T08:57:50Z-
dc.date.available2021-03-01T08:57:50Z-
dc.date.issued2021-01-
dc.identifier.issn0449-3060-
dc.identifier.urihttp://hdl.handle.net/2445/174434-
dc.description.abstractA detailed understanding of the interactions and the best dose-fractionation scheme of radiation to maximize antitumor immunity have not been fully established. In this study, the effect on the host immune system of a single dose of 20 Gy through intraoperative radiation therapy (IORT) on the surgical bed in low-risk breast cancer patients undergoing conserving breast cancer has been assessed. Peripheral blood samples from 13 patients were collected preoperatively and at 48 h and 3 and 10 weeks after the administration of radiation. We performed a flow cytometry analysis for lymphocyte subpopulations, natural killer cells (NK), regulatory T cells (Treg) and myeloid-derived suppressor cells (MDSCs). We observed that the subpopulation of NK CD56+high CD16+ increased significantly at 3 weeks after IORT (0.30-0.42%, P < 0.001), while no changes were found in immunosuppressive profile, CD4+CD25+Foxp3+Helios+ Treg cells, granulocytic MDSCs (G-MDSCs) and monocytic MDSCs (Mo-MDSCs). A single dose of IORT may be an effective approach to improve antitumor immunity based on the increase in NK cells and the non-stimulation of immunosuppressive cells involved in immune escape. These findings support future combinations of IORT with immunotherapy, if they are confirmed in a large cohort of breast cancer patients.-
dc.format.extent9 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherOxford University Press-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1093/jrr/rraa083-
dc.relation.ispartofJournal of Radiation Research, 2021, vol. 62, num. 1, p. 110-118-
dc.relation.urihttps://doi.org/10.1093/jrr/rraa083-
dc.rightscc-by (c) Linares Galiana, Isabel et al., 2021-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Ciències Clíniques)-
dc.subject.classificationCàncer de mama-
dc.subject.classificationRadioteràpia-
dc.subject.classificationImmunoteràpia-
dc.subject.otherBreast cancer-
dc.subject.otherRadiotherapy-
dc.subject.otherImmunotheraphy-
dc.titleChanges in peripheral immune cells after intraoperative radiation therapy in low-risk breast cancer-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec707070-
dc.date.updated2021-03-01T08:57:50Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid33006364-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
707070.pdf1.37 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons